Last reviewed · How we verify
Nux vomica 30C
Nux vomica 30C is a homeopathic preparation with no established pharmacological mechanism of action.
Nux vomica 30C is a homeopathic preparation with no established pharmacological mechanism of action. Used for Various self-reported conditions in homeopathic practice (not validated by clinical evidence).
At a glance
| Generic name | Nux vomica 30C |
|---|---|
| Also known as | Active Nux vomica |
| Sponsor | Shaare Zedek Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Nux vomica is a homeopathic remedy derived from the seed of Strychnos nux-vomica. At 30C potency, the preparation has been diluted beyond the point where any active ingredient remains detectable by standard analytical methods. Homeopathic remedies operate under principles not supported by conventional pharmacology or molecular biology.
Approved indications
- Various self-reported conditions in homeopathic practice (not validated by clinical evidence)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nux vomica 30C CI brief — competitive landscape report
- Nux vomica 30C updates RSS · CI watch RSS
- Shaare Zedek Medical Center portfolio CI